REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

The European Parliament publishes a study on Artificial intelligence in healthcare

The study provides an overview of how Artificial Intelligence (AI) can positively impact future healthcare, increasing the efficiency of clinicians, improving medical diagnosis and treatments, and optimising the allocation of human and technical resources.

The role of AI in medicine and healthcare has been debated at various levels in recent years with controversial interpretations and outcomes.

The report examines the main clinical, social and ethical risks posed by AI in healthcare, such as potential errors and patient harm; risk of bias and increased health inequalities; lack of transparency and trust; and vulnerability to hacking and data privacy breaches.

Mitigation measures and policy options to minimise these risks and maximise the benefits of medical AI are proposed, including multi-stakeholder engagement through the AI production lifetime, increased transparency and traceability, in-depth clinical validation of AI tools, and AI training and education for both clinicians and citizens

The study was promoted by the Panel for the Future of Science and Technology (STOA) and managed by the Scientific Foresight Unit, within the Directorate-General for Parliamentary Research Services (EPRS) of the Secretariat of the European Parliament

Click HERE for the report.


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848098”.

Copyright 2020 REVERT ©  All Rights Reserved